{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:40:09Z","timestamp":1739986809375,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1124\/jpet.113.211557","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T04:48:07Z","timestamp":1395809287000},"page":"402-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of Duloxetine and WAY100635 on Pudendal Inhibition of Bladder Overactivity in Cats"],"prefix":"10.1016","volume":"349","author":[{"given":"Jeremy","family":"Reese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyad","family":"Schwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Matsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jicheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Roppolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"de Groat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changfeng","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3, Suppl 1","key":"10.1124\/jpet.113.211557_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.urology.2003.10.005","article-title":"New pharmacologic targets for the treatment of the overactive bladder: an update","volume":"63","author":"Andersson","year":"2004","journal-title":"Urology"},{"key":"10.1124\/jpet.113.211557_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(00)00622-1","article-title":"Venlafaxine and its interaction with WAY 100635: effects on serotonergic unit activity and behavior in cats","volume":"404","author":"Bjorvatn","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.211557_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","article-title":"The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis","volume":"54","author":"Chapple","year":"2008","journal-title":"Eur Urol"},{"key":"10.1124\/jpet.113.211557_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.eururo.2012.10.048","article-title":"Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a \u03b2(3)-adrenoceptor agonist, in overactive bladder","volume":"63","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"key":"10.1124\/jpet.113.211557_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.urology.2010.08.039","article-title":"National community prevalence of overactive bladder in the United States stratified by sex and age","volume":"77","author":"Coyne","year":"2011","journal-title":"Urology"},{"key":"10.1124\/jpet.113.211557_bib6","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-3565(25)10634-4","article-title":"Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat","volume":"274","author":"Danuser","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"6A, Suppl","key":"10.1124\/jpet.113.211557_bib7","first-page":"36","article-title":"A neurologic basis for the overactive bladder","volume":"50","author":"de Groat","year":"1997","journal-title":"ACS Chem Biol"},{"key":"10.1124\/jpet.113.211557_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/WNF.0b013e3182613dce","article-title":"Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study","volume":"35","author":"Di Rezze","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/jpet.113.211557_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0022-3565(25)20660-7","article-title":"WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135","volume":"278","author":"Fornal","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.211557_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn2401","article-title":"The neural control of micturition","volume":"9","author":"Fowler","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.113.211557_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s002130050238","article-title":"Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms","volume":"130","author":"Gartside","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.211557_bib12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0022-3565(25)09547-3","article-title":"Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats","volume":"273","author":"Gobert","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.211557_bib13","first-page":"259","article-title":"Duloxetine in the treatment of stress urinary incontinence","volume":"1","author":"Jost","year":"2005","journal-title":"Ther Clin Risk Manag"},{"key":"10.1124\/jpet.113.211557_bib14","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0024-3205(02)01848-9","article-title":"Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats","volume":"71","author":"Katofiasc","year":"2002","journal-title":"Life Sci"},{"key":"10.1124\/jpet.113.211557_bib15","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.juro.2012.09.095","article-title":"Role of opioid and metabotropic glutamate 5 receptors in pudendal inhibition of bladder overactivity in cats","volume":"189","author":"Mally","year":"2013","journal-title":"J Urol"},{"key":"10.1124\/jpet.113.211557_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(90)91303-X","article-title":"[3H]prazosin binding in the intermediolateral cell column and the effects of iontophoresed methoxamine on sympathetic preganglionic neuronal activity in the anaesthetized cat and rat","volume":"530","author":"Marks","year":"1990","journal-title":"Brain Res"},{"key":"10.1124\/jpet.113.211557_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.expneurol.2013.05.006","article-title":"Effect of methysergide on pudendal inhibition of micturition reflex in cats","volume":"247","author":"Matsuta","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1124\/jpet.113.211557_bib18","first-page":"125","article-title":"The segmental detailed topographical distribution of monoaminergic terminals and their pathways in the spinal cord of the cat","volume":"147","author":"Mizukawa","year":"1980","journal-title":"Anat Anz"},{"key":"10.1124\/jpet.113.211557_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.902010308","article-title":"The distribution of visceral primary afferents from the pelvic nerve to Lissauer\u2019s tract and the spinal gray matter and its relationship to the sacral parasympathetic nucleus","volume":"201","author":"Morgan","year":"1981","journal-title":"J Comp Neurol"},{"key":"10.1124\/jpet.113.211557_bib20","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/cr078224o","article-title":"Serotonin receptors","volume":"108","author":"Nichols","year":"2008","journal-title":"Chem Rev"},{"key":"10.1124\/jpet.113.211557_bib21","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"10.1124\/jpet.113.211557_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/nau.20174","article-title":"Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial","volume":"24","author":"Peters","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1124\/jpet.113.211557_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/nau.20823","article-title":"Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptoms","volume":"29","author":"Peters","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1124\/jpet.113.211557_bib24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.juro.2009.05.045","article-title":"Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial","volume":"182","author":"Peters","year":"2009","journal-title":"J Urol"},{"key":"10.1124\/jpet.113.211557_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/YIC.0b013e328364381b","article-title":"Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine","volume":"28","author":"Robinson","year":"2013","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1124\/jpet.113.211557_bib26","doi-asserted-by":"crossref","first-page":"F663","DOI":"10.1152\/ajprenal.00105.2013","article-title":"Involvement of 5-HT3 receptors in pudendal inhibition of bladder overactivity in cats","volume":"305","author":"Schwen","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.113.211557_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1464-410X.2007.06980.x","article-title":"Duloxetine compared with placebo for treating women with symptoms of overactive bladder","volume":"100","author":"Steers","year":"2007","journal-title":"BJU Int"},{"key":"10.1124\/jpet.113.211557_bib28","doi-asserted-by":"crossref","first-page":"F1090","DOI":"10.1152\/ajprenal.00609.2011","article-title":"Differential role of opioid receptors in tibial nerve inhibition of nociceptive and nonnociceptive bladder reflexes in cats","volume":"302","author":"Tai","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.113.211557_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.expneurol.2006.01.007","article-title":"Suppression of bladder reflex activity in chronic spinal cord injured cats by activation of serotonin 5-HT1A receptors","volume":"199","author":"Tai","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1124\/jpet.113.211557_bib30","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0022-3565(25)10548-X","article-title":"Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat","volume":"274","author":"Thor","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.211557_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cne.902880206","article-title":"Organization of afferent and efferent pathways in the pudendal nerve of the female cat","volume":"288","author":"Thor","year":"1989","journal-title":"J Comp Neurol"},{"key":"10.1124\/jpet.113.211557_bib32","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.juro.2007.07.032","article-title":"Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study","volume":"178","author":"van Kerrebroeck","year":"2007","journal-title":"J Urol"},{"key":"10.1124\/jpet.113.211557_bib33","doi-asserted-by":"crossref","first-page":"F1576","DOI":"10.1152\/ajprenal.00107.2012","article-title":"Inhibition of bladder overactivity by a combination of tibial neuromodulation and tramadol treatment in cats","volume":"302","author":"Zhang","year":"2012","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.211557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:23:40Z","timestamp":1739985820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524186971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0022356524186971"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.211557","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Duloxetine and WAY100635 on Pudendal Inhibition of Bladder Overactivity in Cats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.211557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}